HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Urogenital Tuberculosis

Subscribe to New Research on Urogenital Tuberculosis

A general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female.

Also Known As:

Tuberculosis, Urogenital; Tuberculoses, Urogenital; Urogenital Tuberculoses

Networked: 98 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Bacterial Infections and Mycoses
- Bacterial Infections: 10283
  - Gram-Positive Bacterial Infections: 158
    - Actinomycetales Infections: 1
      - Mycobacterium Infections: 56
        Tuberculosis: 29301
        Urogenital Tuberculosis: 98
        Renal Tuberculosis: 268
        Female Genital Tuberculosis: 64
        Male Genital Tuberculosis: 7
Male Urogenital Diseases
- Urogenital Tuberculosis: 98
  - Renal Tuberculosis: 268
  - Male Genital Tuberculosis: 7
Female Urogenital Diseases and Pregnancy Complications
- Female Urogenital Diseases
  - Urogenital Tuberculosis: 98
    - Renal Tuberculosis: 268
    - Female Genital Tuberculosis: 64

Related Diseases

1.	Fibrosis (Cirrhosis)
2.	Tuberculosis (Tuberculoses)
3.	Inflammation
4.	Systemic Lupus Erythematosus (Libman-Sacks Disease)
5.	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)

Experts

1.	Varalakshmi, P: 2 articles (12/2004 - 03/2004)
2.	Jenita, X: 2 articles (12/2004 - 03/2004)
3.	Kalaiselvi, P: 2 articles (12/2004 - 03/2004)
4.	Srinivasan, S: 2 articles (12/2004 - 03/2004)
5.	Muthu, V: 2 articles (12/2004 - 03/2004)
6.	Mehdipour-Aghabagher, B: 1 article (02/2012)
7.	Pourmand, G: 1 article (02/2012)
8.	Hadadi, A: 1 article (02/2012)
9.	Baylan, O: 1 article (07/2005)
10.	Ozgul, A: 1 article (07/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Urogenital Tuberculosis:

1.	Antitubercular AgentsIBA 01/01/1959 - "[Therapy of urogenital tuberculosis with continuous intravenous infusion of tuberculostatic agents]." 01/01/1994 - "Despite the efficacy of new tuberculostatic agents, urogenital tuberculosis still constitutes a threat to renal function due to fibrosis secondary to healing of the lesions. " 01/01/1998 - "It is most expedient to develop effective modes of improving the etiotropic therapy of urogenital tuberculosis, by applying the multipronged approach which includes chemoenzyme therapy with native and immobilized terrilytine, enhanced activity of basic tuberculostatic agents through their combination with nonspecific antibiotics and the use of helium-neon laser, and delivery of drugs just to the focus of tuberculous inflammation by endolymphatic injection."
2.	cyacetacideIBA 03/31/1955 - "[Cyanoacetic acid hydrazide as treatment of urogenital tuberculosis; trial application as sole medication]." 01/01/1957 - "[Treatment of urogenital tuberculosis with cyanoacetic acid hydrazide (reazide combinations)]."
3.	Streptomycin (Streptomycin Sulfate)FDA Link 01/01/1953 - "Aspects of urogenital tuberculosis in Finland after the introduction of streptomycin." 05/20/1952 - "[125 Cases of urogenital tuberculosis treated with streptomycin; clinical considerations]." 10/27/1951 - "[Streptomycin therapy of urogenital tuberculosis]." 05/01/1951 - "[Streptomycin in urogenital tuberculosis]." 01/01/1951 - "[Results with streptomycin and PAS in urogenital tuberculosis therapy]."
4.	Isoniazid (Ftivazide)FDA LinkGeneric 05/01/1962 - "A case of urogenital tuberculosis caused by low-virulent isoniazid sensitive tubercle bacteria." 04/25/1959 - "[Use of isoniazid para-aminosalicylate in treatment of urogenital tuberculosis]." 06/01/1958 - "[Incidence of isoniazid therapy of urogenital tuberculosis on laboratory tests]." 01/01/1955 - "[An isonicotinic-acid-hydrazide treated case of urogenital tuberculosis with bacilli non-pathogenetic to guinea pigs]." 07/10/1954 - "[Experience with isoniazid in urogenital tuberculosis]."
5.	Anti-Bacterial Agents (Antibiotics)IBA 01/01/1989 - "Direct endolymphatic administration of broad-spectrum antibiotics was used in treatment of approximately 21 patients with complicated urogenital tuberculosis. " 11/01/1974 - "[Secondary microflora in urogenital tuberculosis and its sensitivity to antibiotics]." 12/05/1952 - "[Urogenital tuberculosis; therapy with antibiotics of specific action, observations and results]." 03/11/1952 - "[Evaluation of antibiotics in the treatment of urogenital tuberculosis; survey of 1951-52 period]." 01/01/1989 - "It was shown expedient to use endolymphatic administration of antibiotics in treatment of complicated urogenital tuberculosis alone or in combination with the preoperative procedures."
6.	Tuberculin (PPD)IBA 07/01/1979 - "[Importance of the reaction to determine the index of tuberculin neutrophil injury in the diagnosis of urogenital tuberculosis]." 07/01/1958 - "[Comparative studies on tuberculin cytolysis in urogenital tuberculosis; urine cytolysis test]." 01/01/1958 - "[Comparative studies of tuberculin cytolysis in urogenital tuberculosis]."
7.	Adrenal Cortex Hormones (Corticosteroids)IBA 01/01/1994 - "The authors studied the place of corticosteroids, and endoscopic and percutaneous procedures in the treatment of 86 cases of urogenital tuberculosis. " 04/21/1978 - "Modern therapy of urogenital tuberculosis is divisible into conservative, purely medicamentous treatment, possibly in combination with corticosteroids, and operative therapy, procedures preserving organs and rational eradication of tuberculous processes having to be carefully weighed against each other. " 11/07/1980 - "The support of an effective drug therapy by corticosteroids in the exudative florid initial stage of urogenital tuberculosis for the prevention of specific strictures with threatened organic loss continues to be given. "
8.	Vitamin E FDA LinkGeneric 12/01/2004 - "Oxidative stress in urogenital tuberculosis patients: a predisposing factor for renal stone formation--amelioration by vitamin E supplementation." 03/01/2004 - "Salubrious effect of vitamin E supplementation on renal stone forming risk factors in urogenital tuberculosis patients." 12/01/2004 - "Advocation of vitamin E enhanced the antioxidant status of the plasma, thereby preventing membrane injury, consequently reducing the risk of stone formation in urogenital tuberculosis patients, who were treated with their routine anti-tuberculosis drug regimen."
9.	Rifampin (Rifampicin)FDA LinkGeneric 05/01/1972 - "[Rifampicin in the treatment of urogenital tuberculosis. " 01/01/1969 - "[Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)]."
10.	Ethambutol (Myambutol)FDA LinkGeneric 10/01/1978 - "The present therapy of the urogenital tuberculosis is based on the effective medicaments (rifampizin, isonicotinic acid hydrazid, streptomycin, and ethambutol). " 01/01/1969 - "[Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)]."

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 07/01/1984 - "[Principles of drug therapy in urogenital tuberculosis]." 04/07/1983 - "[Ambulatory chemotherapy of urogenital tuberculosis and its side effects]." 10/01/1978 - "[Effectiveness of different chemotherapy methods in urogenital tuberculosis]." 02/01/1978 - "[Kidney function in intravenous chemotherapy for urogenital tuberculosis]." 02/01/1972 - "[Epidemiology of urogenital tuberculosis, its drug therapy, analysis, and prognosis of own patients]."
2.	Nephrectomy 12/01/1978 - "[Current indications for nephrectomy in patients with urogenital tuberculosis]." 05/01/1974 - "[Nephrectomy in urogenital tuberculosis]." 05/01/1969 - "[Current status of nephrectomy in medico-surgical treatment of urogenital tuberculosis]." 10/01/1962 - "[Relapses, after nephrectomy, of urogenital tuberculosis. " 10/01/1978 - "On the basis of own experiences of twenty years and taking into consideration the knowledge of other authors the developmental tendency in the treatment of the urogenital tuberculosis is demonstrated, the indications to nephrectomy, resection of the kidney, and epididymectomy are reified as well as kind and sequelae of errors in chemotherapy analysed. "
3.	Aftercare (After-Treatment) 10/01/1978 - "[Modern therapy and after-care in urogenital tuberculosis]." 04/01/1978 - "The success of treatment in the Berlin district, especially in the combat against urogenital tuberculosis, which refer to a more than 12 years observation period, are traced back to a continuity of initial stay in an urological clinic in connection with special procedures, following continued ambulant treatment and final after-care." 01/01/1969 - "[Ambulatory after care of patients with urogenital tuberculosis]."
4.	Lasers (Laser) 01/01/1998 - "[Intravascular laser radiation of blood in the multimodality treatment of patients with urogenital tuberculosis]." 01/01/1998 - "It is most expedient to develop effective modes of improving the etiotropic therapy of urogenital tuberculosis, by applying the multipronged approach which includes chemoenzyme therapy with native and immobilized terrilytine, enhanced activity of basic tuberculostatic agents through their combination with nonspecific antibiotics and the use of helium-neon laser, and delivery of drugs just to the focus of tuberculous inflammation by endolymphatic injection."
5.	Cystectomy 01/01/1950 - "[Cystectomy in urogenital tuberculosis]."